Litcius/Paper detail

<i>N</i>-Glycan and Glycopeptide Serum Biomarkers in Philippine Lung Cancer Patients Identified Using Liquid Chromatography–Tandem Mass Spectrometry

Michael Russelle Alvarez, Qingwen Zhou, Jennyfer Tena, Carlito B. Lebrilla, Gladys C. Completo, Francisco M. Heralde, M. Cabanatan, Ma. Teresa Barzaga, N. Tan-Liu, Guia Imelda Ladrera, Jose Luis J. Danguilan, Jomar F. Rabajante, Isagani Padolina, Ruel C. Nacario

2022ACS Omega15 citationsDOIOpen Access PDF

Abstract

-glycans and site-specific glycans are differentially expressed between cases and controls. This report represents the first serum glycan and glycopeptide biomarkers of Philippine lung cancer patients, further demonstrating the utility of mass spectrometry-based glycomic and glycoproteomic methods.

Topics & Concepts

GlycanGlycopeptideLung cancerBiomarkerGlycosylationBiomarker discoveryCancerChemistryGlycoproteinMedicineOncologyProteomicsBiochemistryInternal medicineGeneAntibioticsGlycosylation and Glycoproteins ResearchLung Cancer Research StudiesCarbohydrate Chemistry and Synthesis
<i>N</i>-Glycan and Glycopeptide Serum Biomarkers in Philippine Lung Cancer Patients Identified Using Liquid Chromatography–Tandem Mass Spectrometry | Litcius